about
Evidence for enhanced multisensory facilitation with stimulus relevance: an electrophysiological investigation.Estimation of effective connectivity via data-driven neural modeling.Model-based estimation of intra-cortical connectivity using electrophysiological data.Seizure Prediction: Science Fiction or Soon to Become Reality?A data-driven framework for neural field modeling.A Generalizable Brain-Computer Interface (BCI) Using Machine Learning for Feature DiscoveryIntrinsic excitability measures track antiepileptic drug action and uncover increasing/decreasing excitability over the wake/sleep cycle.Epilepsy: Ever-changing states of cortical excitability.Electrical probing of cortical excitability in patients with epilepsy.Exploring the tolerability of spatiotemporally complex electrical stimulation paradigms.Human focal seizures are characterized by populations of fixed duration and interval.Placement of deep brain electrodes in the dog using the Brainsight frameless stereotactic system: a pilot feasibility study.A method for actively tracking excitability of brain networks using a fully implantable monitoring system.Probing for cortical excitability.Seizure severity and duration in the cortical stimulation model of experimental epilepsy in rats: a longitudinal study.Spatiotemporal multi-resolution approximation of the Amari type neural field model.The thalamocortical circuit and the generation of epileptic spikes in rat models of focal epilepsy.Closed-loop seizure control with very high frequency electrical stimulation at seizure onset in the GAERS model of absence epilepsy.Bifurcation analysis of two coupled Jansen-Rit neural mass models.A neural mass model of spontaneous burst suppression and epileptic seizures.Seizure pathways: A model-based investigationPatient-specific bivariate-synchrony-based seizure prediction for short prediction horizonsElectrical stimulation of neural tissue modeled as a cellular composite: point source electrode in an isotropic tissueForecasting cycles of seizure likelihoodWhen can we trust responders? Serious concerns when using 50% response rate to assess clinical trials
P50
Q30458839-AB9F861E-F643-44EF-B364-A86C80B98915Q30878225-FE64FCBC-48B7-4D8A-A955-B5794CBDB768Q30977064-BCDDACEA-4CF6-4A5E-ACE7-61FCA4702131Q33361580-4BF7B5F6-E8BA-45C9-9B21-4BF50F600BB3Q33823283-46BB375E-D27F-44A7-B35E-AAF76A36E04AQ35675596-17A4B944-49F5-4EE7-9005-8FA9B0FD3892Q36331914-5399DB30-7EA3-4983-9097-7A875DDC3D98Q38027697-84954A43-B6E5-4570-9B0F-799AFBB1D6E6Q39679514-FA48C90B-9B0E-48BC-90EC-20EC28AEDACEQ39724139-FDD8AC14-7750-4700-8DD8-C0B8816AE41DQ40158208-3CB40AE4-F44E-4846-9E38-83FCC1DF5C86Q42133519-E2B09E11-B53E-4FCC-A6ED-72C35896DD26Q44390907-EE902A67-D36E-46BE-9A71-485D584EE073Q48263600-AFF4AFC9-FCAA-4CA5-98F1-24AC314A28CAQ48308348-F6704002-056D-41E8-A156-92AD9AA35D3CQ48312170-FCEF775C-3DE3-47F3-91B5-7FA00C7704D9Q48388417-6C091C68-78CA-44F9-A370-9C74D3B2711FQ51585006-5AD489BD-4CC6-420A-A7A8-6DA45ED8796AQ52627979-1B184D5E-F013-4D16-B141-BA15FA13B6C4Q54794121-D5DCEC83-50A7-4F3F-85FC-553C12D39A8AQ57281637-DA116077-58A4-4E36-A776-2A227E954D95Q60623640-C2EE9D4F-7308-46D1-97FE-6BDCCE36308AQ86496045-EF07CAFB-01DA-4932-9E31-9F82D7A735E3Q90704895-6CFD9E14-160E-4DAB-BA56-EB0692B54A87Q93026088-8EF3045C-F235-4AC2-96F3-73F50CBEB3B1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dean Freestone
@ast
Dean Freestone
@en
Dean Freestone
@es
Dean Freestone
@nl
Dean Freestone
@sl
type
label
Dean Freestone
@ast
Dean Freestone
@en
Dean Freestone
@es
Dean Freestone
@nl
Dean Freestone
@sl
prefLabel
Dean Freestone
@ast
Dean Freestone
@en
Dean Freestone
@es
Dean Freestone
@nl
Dean Freestone
@sl
P106
P1153
35408997900
P2456
P31
P496
0000-0003-2411-5358